Hollow Mesoporous Zirconia Nanocapsules for Drug Delivery

Hollow mesoporous zirconia nanocapsules (hm‐ZrO2) with a hollow core/porous shell structure are demonstrated as effective vehicles for anti‐cancer drug delivery. While the highly porous feature of the shell allows the drug, doxorubicin(DOX), to easily pass through between the inner void space and su...

Full description

Saved in:
Bibliographic Details
Published inAdvanced functional materials Vol. 20; no. 15; pp. 2442 - 2447
Main Authors Tang, Shaoheng, Huang, Xiaoqing, Chen, Xiaolan, Zheng, Nanfeng
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 09.08.2010
WILEY‐VCH Verlag
Subjects
Online AccessGet full text
ISSN1616-301X
1616-3028
DOI10.1002/adfm.201000647

Cover

Loading…
Abstract Hollow mesoporous zirconia nanocapsules (hm‐ZrO2) with a hollow core/porous shell structure are demonstrated as effective vehicles for anti‐cancer drug delivery. While the highly porous feature of the shell allows the drug, doxorubicin(DOX), to easily pass through between the inner void space and surrounding environment of the particles, the void space in the core endows the nanocapsules with high drug loading capacity. The larger the inner hollow diameter, the higher their DOX loading capacity. A loading of 102% related to the weight of hm‐ZrO2 is achieved by the nanocapsules with an inner diameter of 385 nm. Due to their pH‐dependent charge nature, hm‐ZrO2 loaded DOX exhibit pH‐dependent drug releasing kinetics. A lower pH offers a faster DOX release rate from hm‐ZrO2. Such a property makes the loaded DOX easily release from the nanocapsules when up‐taken by living cells. Although the flow cytometry reveals more uptake of hm‐ZrO2 particles by normal cells, hm‐ZrO2 loaded DOX release more drugs in cancer cells than in normal cells, leading to more cytotoxicity toward tumor cells and less cytotoxicity to healthy cells than free DOX. Inorganic nanocapsules improve anticancer drug delivery:Highly biocompatible hollow mesoporous ZrO2 nanospheres exhibit high loading capacity of doxorubicin. DOX loaded ZrO2 nanocapsules release more drugs in cancer cells than in normal cells, therefore displaying more cytotoxicity toward tumor cells and less cytotoxicity to normal cells than free DOX.
AbstractList Hollow mesoporous zirconia nanocapsules ( hm ‐ZrO 2 ) with a hollow core/porous shell structure are demonstrated as effective vehicles for anti‐cancer drug delivery. While the highly porous feature of the shell allows the drug, doxorubicin(DOX), to easily pass through between the inner void space and surrounding environment of the particles, the void space in the core endows the nanocapsules with high drug loading capacity. The larger the inner hollow diameter, the higher their DOX loading capacity. A loading of 102% related to the weight of hm ‐ZrO 2 is achieved by the nanocapsules with an inner diameter of 385 nm. Due to their pH‐dependent charge nature, hm ‐ZrO 2 loaded DOX exhibit pH‐dependent drug releasing kinetics. A lower pH offers a faster DOX release rate from hm ‐ZrO 2 . Such a property makes the loaded DOX easily release from the nanocapsules when up‐taken by living cells. Although the flow cytometry reveals more uptake of hm ‐ZrO 2 particles by normal cells, hm ‐ZrO 2 loaded DOX release more drugs in cancer cells than in normal cells, leading to more cytotoxicity toward tumor cells and less cytotoxicity to healthy cells than free DOX.
Hollow mesoporous zirconia nanocapsules (hm‐ZrO2) with a hollow core/porous shell structure are demonstrated as effective vehicles for anti‐cancer drug delivery. While the highly porous feature of the shell allows the drug, doxorubicin(DOX), to easily pass through between the inner void space and surrounding environment of the particles, the void space in the core endows the nanocapsules with high drug loading capacity. The larger the inner hollow diameter, the higher their DOX loading capacity. A loading of 102% related to the weight of hm‐ZrO2 is achieved by the nanocapsules with an inner diameter of 385 nm. Due to their pH‐dependent charge nature, hm‐ZrO2 loaded DOX exhibit pH‐dependent drug releasing kinetics. A lower pH offers a faster DOX release rate from hm‐ZrO2. Such a property makes the loaded DOX easily release from the nanocapsules when up‐taken by living cells. Although the flow cytometry reveals more uptake of hm‐ZrO2 particles by normal cells, hm‐ZrO2 loaded DOX release more drugs in cancer cells than in normal cells, leading to more cytotoxicity toward tumor cells and less cytotoxicity to healthy cells than free DOX. Inorganic nanocapsules improve anticancer drug delivery:Highly biocompatible hollow mesoporous ZrO2 nanospheres exhibit high loading capacity of doxorubicin. DOX loaded ZrO2 nanocapsules release more drugs in cancer cells than in normal cells, therefore displaying more cytotoxicity toward tumor cells and less cytotoxicity to normal cells than free DOX.
Author Zheng, Nanfeng
Huang, Xiaoqing
Chen, Xiaolan
Tang, Shaoheng
Author_xml – sequence: 1
  givenname: Shaoheng
  surname: Tang
  fullname: Tang, Shaoheng
  organization: State Key Laboratory for Physical Chemistry of Solid Surfaces and Department of Chemistry College of Chemistry and Chemical Engineering, Xiamen University Xiamen 361005 (China)
– sequence: 2
  givenname: Xiaoqing
  surname: Huang
  fullname: Huang, Xiaoqing
  organization: State Key Laboratory for Physical Chemistry of Solid Surfaces and Department of Chemistry College of Chemistry and Chemical Engineering, Xiamen University Xiamen 361005 (China)
– sequence: 3
  givenname: Xiaolan
  surname: Chen
  fullname: Chen, Xiaolan
  organization: State Key Laboratory for Physical Chemistry of Solid Surfaces and Department of Chemistry College of Chemistry and Chemical Engineering, Xiamen University Xiamen 361005 (China)
– sequence: 4
  givenname: Nanfeng
  surname: Zheng
  fullname: Zheng, Nanfeng
  email: nfzheng@xmu.edu.cn
  organization: State Key Laboratory for Physical Chemistry of Solid Surfaces and Department of Chemistry College of Chemistry and Chemical Engineering, Xiamen University Xiamen 361005 (China)
BookMark eNqFj11LwzAUhoNMcJveet0_0Jo0bdJeztVt4jZv_GI3IUsTiWbNSFpn_70dkyGCeHE4L7w85_AMQK-ylQTgEsEIQRhf8VJtohh2GZKEnoA-IoiEGMZZ75jRyxkYeP8GIaIUJ32Qz6wxdhcspLdb62zjg5V2wlaaB0teWcG3vjHSB8q6oHDNa1BIoz-ka8_BqeLGy4vvPQSPk5uH8Syc309vx6N5KHCOaYhjqkS-ViXGeQkVIZhALiESJJU5WitaKpKRjHddinhXZ5BmNElJiinG3QxBdLgrnPXeScW2Tm-4axmCbC_O9uLsKN4ByS9A6JrX2la149r8jeUHbKeNbP95wkbFZPGTDQ-s9rX8PLLcvTNCMU3Z83LKims6pqunOxbjL7Mjfe0
CitedBy_id crossref_primary_10_1039_C9QI00165D
crossref_primary_10_1016_j_ceramint_2024_03_177
crossref_primary_10_1039_c2cc31708g
crossref_primary_10_1002_chem_201303752
crossref_primary_10_1016_j_jddst_2023_104152
crossref_primary_10_1088_1361_6528_abe4fe
crossref_primary_10_1021_bm4002574
crossref_primary_10_1002_cssc_201300416
crossref_primary_10_1016_j_jhazmat_2020_124458
crossref_primary_10_1039_c2ce06411a
crossref_primary_10_1080_13102818_2019_1649094
crossref_primary_10_1002_adhm_201600219
crossref_primary_10_1007_s12274_013_0392_9
crossref_primary_10_1016_j_jtice_2016_05_015
crossref_primary_10_1021_acsami_5b04819
crossref_primary_10_1002_smll_201201735
crossref_primary_10_1016_j_molliq_2020_113307
crossref_primary_10_1016_j_actbio_2015_03_006
crossref_primary_10_1021_nn5027214
crossref_primary_10_1021_acs_molpharmaceut_0c00489
crossref_primary_10_1021_acsami_7b07567
crossref_primary_10_1039_c3ce41542b
crossref_primary_10_1039_C6TB01102K
crossref_primary_10_1039_D2NA00367H
crossref_primary_10_1016_j_matchemphys_2014_02_015
crossref_primary_10_1016_j_porgcoat_2019_105276
crossref_primary_10_1039_c2cs15308d
crossref_primary_10_1007_s11706_023_0631_2
crossref_primary_10_1016_j_porgcoat_2020_106086
crossref_primary_10_1002_anie_202017117
crossref_primary_10_1016_j_ejpb_2014_02_009
crossref_primary_10_1016_j_eml_2016_03_015
crossref_primary_10_1021_acsomega_6b00062
crossref_primary_10_1039_c3nr33695f
crossref_primary_10_1007_s12274_014_0701_y
crossref_primary_10_1016_j_optmat_2012_09_007
crossref_primary_10_1016_j_micromeso_2022_112109
crossref_primary_10_1007_s13204_015_0405_y
crossref_primary_10_1002_adfm_201402755
crossref_primary_10_1016_j_apt_2013_08_005
crossref_primary_10_1016_j_nantod_2014_09_003
crossref_primary_10_1039_C4TA01943A
crossref_primary_10_1021_acsabm_9b01244
crossref_primary_10_1002_adma_201305319
crossref_primary_10_1038_srep46540
crossref_primary_10_1016_j_ejpb_2017_10_012
crossref_primary_10_1039_c2jm15353j
crossref_primary_10_1016_j_tsf_2011_12_028
crossref_primary_10_1002_adma_202005215
crossref_primary_10_1016_j_cej_2017_03_012
crossref_primary_10_1002_adma_201606134
crossref_primary_10_1039_C1JM14303D
crossref_primary_10_3390_coatings13071273
crossref_primary_10_1002_adfm_201101960
crossref_primary_10_1039_c3tb21694b
crossref_primary_10_1039_C7PY00161D
crossref_primary_10_1021_acsami_6b07603
crossref_primary_10_1039_c0jm04115g
crossref_primary_10_1002_zaac_201400340
crossref_primary_10_1016_j_msec_2019_110032
crossref_primary_10_1021_cm202281m
crossref_primary_10_1016_j_ceramint_2021_06_083
crossref_primary_10_5006_1090
crossref_primary_10_3390_ijms241914687
crossref_primary_10_1039_C5TA00417A
crossref_primary_10_1039_C7RA04358A
crossref_primary_10_1002_ange_201105190
crossref_primary_10_1002_wnan_132
crossref_primary_10_1007_s11051_017_3971_y
crossref_primary_10_1002_smll_201401360
crossref_primary_10_1007_s12039_017_1296_0
crossref_primary_10_1039_c1dt10996k
crossref_primary_10_1016_j_micromeso_2019_109886
crossref_primary_10_1039_C4CP05733C
crossref_primary_10_1039_C6RA23761D
crossref_primary_10_1021_ja203316q
crossref_primary_10_1039_c1ee01123e
crossref_primary_10_1039_c2jm32020g
crossref_primary_10_1007_s11242_021_01618_x
crossref_primary_10_1016_j_jallcom_2018_08_308
crossref_primary_10_1016_j_msec_2014_12_079
crossref_primary_10_1021_acs_inorgchem_1c00718
crossref_primary_10_1016_j_ejmcr_2023_100126
crossref_primary_10_1016_j_jallcom_2017_10_138
crossref_primary_10_1002_anie_201105190
crossref_primary_10_1007_s10971_022_05747_7
crossref_primary_10_1021_acs_est_6b05295
crossref_primary_10_1039_c3dt50243k
crossref_primary_10_1016_j_matlet_2013_04_077
crossref_primary_10_1039_c1cc10659g
crossref_primary_10_1016_j_ceramint_2022_01_127
crossref_primary_10_1002_ange_202017117
crossref_primary_10_1021_acsbiomaterials_6b00093
crossref_primary_10_1016_j_partic_2013_06_003
crossref_primary_10_1039_C4CE02037E
crossref_primary_10_1016_j_jcis_2011_11_055
crossref_primary_10_1016_j_actbio_2011_06_028
crossref_primary_10_1002_tcr_202300018
crossref_primary_10_1021_am5068723
crossref_primary_10_1016_j_apsusc_2019_07_047
crossref_primary_10_1039_c3tb20365d
crossref_primary_10_1021_am200364e
crossref_primary_10_1021_am4031104
crossref_primary_10_1039_c3nr34006f
crossref_primary_10_1039_C4BM00158C
crossref_primary_10_54097_hset_v6i_957
crossref_primary_10_1002_tcr_202200084
crossref_primary_10_1039_C5TB00832H
crossref_primary_10_1016_j_actbio_2017_11_049
crossref_primary_10_1016_j_colsurfa_2024_134427
crossref_primary_10_1039_C5RA05489C
crossref_primary_10_1021_am405375s
crossref_primary_10_1021_acsmacrolett_6b00447
crossref_primary_10_1007_s10971_015_3707_3
crossref_primary_10_3390_nano11092166
crossref_primary_10_1002_asia_201701204
crossref_primary_10_1016_j_micromeso_2013_06_015
crossref_primary_10_1021_acsanm_2c04425
crossref_primary_10_1016_j_ccr_2013_03_007
crossref_primary_10_1208_s12249_017_0740_2
crossref_primary_10_1016_j_biomaterials_2011_12_014
crossref_primary_10_1021_ja211279u
crossref_primary_10_1016_j_jddst_2022_103957
crossref_primary_10_1007_s00396_012_2716_9
crossref_primary_10_1016_j_biomaterials_2012_10_002
crossref_primary_10_1021_la402080y
crossref_primary_10_1016_j_mtcomm_2024_108541
crossref_primary_10_1016_j_jallcom_2011_06_111
crossref_primary_10_1038_s43586_022_00104_y
crossref_primary_10_1016_j_apsusc_2019_06_187
crossref_primary_10_1016_j_actbio_2013_10_028
crossref_primary_10_1038_srep07638
crossref_primary_10_1016_j_jhazmat_2020_122530
crossref_primary_10_1021_ja4083792
crossref_primary_10_1021_nn3011703
crossref_primary_10_1002_adfm_201200082
crossref_primary_10_1039_c3cp54899f
crossref_primary_10_1016_j_biomaterials_2010_09_069
crossref_primary_10_1039_C2NR33130F
crossref_primary_10_1039_C4RA13735C
crossref_primary_10_1039_C6RA00673F
crossref_primary_10_1039_c3tb20068j
crossref_primary_10_1016_j_msec_2016_08_060
crossref_primary_10_1007_s10853_013_7726_6
crossref_primary_10_1039_C4NR03746D
crossref_primary_10_1021_jacs_6b00773
crossref_primary_10_1039_C4TB00416G
crossref_primary_10_1039_D1CS01022K
crossref_primary_10_1016_j_addr_2020_06_020
crossref_primary_10_1080_00150193_2013_845483
crossref_primary_10_1039_C1CE06155K
crossref_primary_10_1016_j_mtcomm_2020_101378
crossref_primary_10_1021_acsomega_2c00060
crossref_primary_10_1039_c3ra40992a
crossref_primary_10_1021_acs_langmuir_6b02954
crossref_primary_10_1021_la304551y
crossref_primary_10_1039_c4tb00507d
crossref_primary_10_1039_C6RA07444H
crossref_primary_10_1039_C2RA22261B
crossref_primary_10_1007_s12274_012_0252_z
crossref_primary_10_1039_C4DT03113J
crossref_primary_10_1007_s10934_017_0508_9
crossref_primary_10_1016_j_actbio_2013_05_006
crossref_primary_10_1021_ja309142j
crossref_primary_10_1039_C3TA13447D
crossref_primary_10_3390_pharmaceutics14010110
crossref_primary_10_1016_j_apcatb_2019_05_021
crossref_primary_10_1039_C4DT02549K
crossref_primary_10_3390_polym7020235
crossref_primary_10_1016_j_ceramint_2014_03_016
crossref_primary_10_1016_j_msec_2015_11_010
crossref_primary_10_1016_j_matchemphys_2012_07_043
crossref_primary_10_1016_j_carbpol_2022_119458
Cites_doi 10.1002/anie.200803387
10.1021/nn800072t
10.1021/ja028650l
10.1021/nn800669n
10.1021/ja710193c
10.1021/ja807798g
10.1111/j.1551-2916.2008.02722.x
10.1007/s11095-008-9811-0
10.1039/b914842f
10.1038/nmat2118
10.1046/j.1469-7580.2002.00059.x
10.1021/ja046275m
10.1016/S0009-2509(03)00234-3
10.1002/smll.200800808
10.1016/S0167-8140(84)80077-8
10.1021/ja051113r
10.1016/j.addr.2008.03.016
10.1021/nn700040t
10.2174/138955708783498078
10.1002/adfm.200601217
10.1016/j.addr.2008.03.012
10.1021/cm052580a
10.1039/b806051g
10.1016/j.jconrel.2004.03.005
10.1002/chem.200600226
10.1016/j.chembiol.2003.09.011
10.1016/S1053-4296(98)80043-X
10.1007/s12030-008-9003-3
10.1021/ja0772086
10.1016/S0046-8177(75)80045-1
10.1166/jbn.2009.1005
10.1002/anie.200503389
10.4028/www.scientific.net/KEM.377.133
10.1039/b902462j
10.1021/ja803688x
10.1039/b800389k
10.1002/anie.200902208
10.1021/ja803383k
10.1021/ja073506r
10.1002/adfm.200601191
10.1021/ar700089b
10.1158/0008-5472.CAN-08-1468
10.1002/anie.200603507
10.1517/17425247.1.1.57
ContentType Journal Article
Copyright Copyright © 2010 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: Copyright © 2010 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID BSCLL
AAYXX
CITATION
DOI 10.1002/adfm.201000647
DatabaseName Istex
CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1616-3028
EndPage 2447
ExternalDocumentID 10_1002_adfm_201000647
ADFM201000647
ark_67375_WNG_DB7C7ZVK_2
Genre article
GroupedDBID -~X
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
23M
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
EBS
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SUPJJ
UB1
V2E
W8V
W99
WBKPD
WFSAM
WIH
WIK
WJL
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XPP
XV2
~IA
~WT
AAHQN
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGQPQ
AGYGG
CITATION
ID FETCH-LOGICAL-c3937-327fc9bfd339d0f66360ae01c65e91bf7df6868ad0f51a6638078745653733373
IEDL.DBID DR2
ISSN 1616-301X
IngestDate Tue Jul 01 01:29:55 EDT 2025
Thu Apr 24 23:01:28 EDT 2025
Wed Jan 22 16:51:45 EST 2025
Wed Oct 30 09:52:12 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 15
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3937-327fc9bfd339d0f66360ae01c65e91bf7df6868ad0f51a6638078745653733373
Notes ArticleID:ADFM201000647
ark:/67375/WNG-DB7C7ZVK-2
istex:5BEC9E87C95FF51F4F4D204A871C4DFDFDB68C67
PageCount 6
ParticipantIDs crossref_primary_10_1002_adfm_201000647
crossref_citationtrail_10_1002_adfm_201000647
wiley_primary_10_1002_adfm_201000647_ADFM201000647
istex_primary_ark_67375_WNG_DB7C7ZVK_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 9, 2010
PublicationDateYYYYMMDD 2010-08-09
PublicationDate_xml – month: 08
  year: 2010
  text: August 9, 2010
  day: 09
PublicationDecade 2010
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
PublicationTitle Advanced functional materials
PublicationTitleAlternate Adv. Funct. Mater
PublicationYear 2010
Publisher WILEY-VCH Verlag
WILEY‐VCH Verlag
Publisher_xml – name: WILEY-VCH Verlag
– name: WILEY‐VCH Verlag
References W. Zhao, J. Gu, L. Zhang, H. Chen, J. Shi, J. Am. Chem. Soc. 2005, 127, 8916.
I. I. Slowing, B. G. Trewyn, S. Giri, V. S. Y. Lin, Adv. Funct. Mater. 2007, 17, 1225.
A. Bianco, Expert Opin. Drug Delivery 2004, 1, 57.
X. Q. Huang, C. Y. Guo, L. Q. Zuo, N. F. Zheng, G. D. Stucky, Small 2009, 5, 361.
M. Y. Ma, Y. J. Zhu, L. Li, S. W. Cao, J. Mater. Chem. 2008, 18, 2722.
D. Davis, U. Akhtar, B. Keaster, K. Grozinger, L. Washington, S. Kelsey, A. Sarkar, R. K. DeLong, J. Biomed. Nanotechnol. 2009, 5, 36.
C. S. S. R. Kumar, Nanomaterials for Cancer Therapy, 1st ed., Wiley-VCH, Weinheim 2006.
Z. Liu, J. T. Robinson, X. M. Sun, H. J. Dai, J. Am. Chem. Soc. 2008, 130, 10876.
P. M. Arnal, M. Comotti, F. Schuth, Angew. Chem. Int. Ed. 2006, 45, 8224.
H. S. Nalwa, T. J. Webster, Cancer Nanotechnology: Nanomaterials for Cancer Diagnosis and Therapy, American Scientific Publishers, Stevenson Ranch, CA 2007.
M. Vallet-Regi, Chem. -Eur. J. 2006, 12, 5934.
I. Izquierdo-Barba, M. Manzano, M. Colilla, M. Vallet-Regi, Key Eng. Mater. 2008, 377, 133.
W. J. Rieter, K. M. Pott, K. M. L. Taylor, W. Lin, J. Am. Chem. Soc. 2008, 130, 11584.
E. Boisselier, D. Astruc, Chem. Soc. Rev. 2009, 38, 1759.
M. Colilla, M. Manzano, M. Vallet-Regi, Int. J. Nanomed. 2008, 3, 403.
M. Liong, J. Lu, M. Kovochich, T. Xia, S. G. Ruehm, A. E. Nel, F. Tamanoi, J. I. Zink, ACS Nano 2008, 2, 889.
N. W. S. Kam, Z. Liu, H. Dai, Angew. Chem. Int. Ed. 2006, 45, 577.
Y. Klichko, M. Liong, E. Choi, S. Angelos, A. E. Nel, J. F. Stoddart, F. Tamanoi, J. I. Zink, J. Am. Ceram. Soc. 2008, 92, S2.
A. Corma, U. Diaz, M. Arrrica, E. Fernandez, I. Ortega, Angew. Chem. Int. Ed. 2009, 48, 6247.
C.-Y. Lai, B. G. Trewyn, D. M. Jeftinija, K. Jeftinija, S. Xu, S. Jeftinija, V. S. Y. Lin, J. Am. Chem. Soc. 2003, 125, 4451.
Z. Liu, X. M. Sun, N. Nakayama-Ratchford, H. J. Dai, ACS Nano 2007, 1, 50.
D. R. Radu, C.-Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, V. S. Y. Lin, J. Am. Chem. Soc. 2004, 126, 13216.
J. Lu, M. Liong, S. Sherman, T. Xia, M. Kovochich, A. E. Nel, J. I. Zink, F. Tamanoi, NanoBiotechnology 2007, 3, 89.
K. Patel, S. Angelos, W. R. Dichtel, A. Coskun, Y.-W. Yang, J. I. Zink, J. F. Stoddart, J. Am. Chem. Soc. 2008, 130, 2382.
D. Pantarotto, D. Partidos Charalambos, J. Hoebeke, F. Brown, E. Kramer, J.-P. Briand, S. Muller, M. Prato, A. Bianco, Chem. Biol. 2003, 10, 961.
P. M. Arnal, C. Weidenthaler, F. Schuth, Chem. Mater. 2006, 18, 2733.
A. L. Doadrio, E. M. B. Sousa, J. C. Doadrio, J. Perez Pariente, I. Izquierdo-Barba, M. Vallet-Regi, J. Controlled Release 2004, 97, 125.
S. Angelos, E. Johansson, J. F. Stoddart, J. I. Zink, Adv. Funct. Mater. 2007, 17, 2261.
I. I. Slowing, J. L. Vivero-Escoto, C.-W. Wu, V. S. Y. Lin, Adv. Drug Delivery Rev. 2008, 60, 1278.
W. J. Rieter, K. M. L. Taylor, W. Lin, J. Am. Chem. Soc. 2007, 129, 9852.
G. Pastorin, Pharm. Res. 2009, 26, 746.
J. L. Wike-Hooley, J. Haveman, H. S. Reinhold, Radiother. Oncol. 1984, 2, 343.
D. P. Ferris, Y.-L. Zhao, N. M. Khashab, H. A. Khatib, J. F. Stoddart, J. I. Zink, J. Am. Chem. Soc. 2009, 131, 1686.
V. Pathak, Nanotechnology for Cancer Therapy, Pearl Books, New Delhi 2007.
W. Lin, J. W. Rieter, K. M. L. Taylor, Angew. Chem. Int. Ed. 2009, 48, 650.
J. A. Firth, J. Anat. 2002, 200, 541.
M. Liong, S. Angelos, E. Choi, K. Patel, J. F. Stoddart, J. I. Zink, J. Mater. Chem. 2009, 19, 6251.
J. Cheon, J. Mater. Chem. 2009, 19, 6249.
K. M. L. Taylor, J. S. Kim, W. J. Rieter, H. An, W. Lin, W. Lin, J. Am. Chem. Soc. 2008, 130, 2154.
M. Prato, K. Kostarelos, A. Bianco, Acc. Chem. Res. 2008, 41, 60.
Z. Liu, K. Chen, C. Davis, S. Sherlock, Q. Cao, X. Chen, H. Dai, Cancer Res. 2008, 68, 6652.
Y. Piao, J. Kim, H. Bin Na, D. Kim, J. S. Baek, M. K. Ko, J. H. Lee, M. Shokouhimehr, T. Hyeon, Nat. Mater. 2008, 7, 242.
A. Hirano, T. Matsui, Hum. Pathol. 1975, 6, 611.
S. S. Feng, S. Chien, Chem. Eng. Sci. 2003, 58, 4087.
T. Murakami, K. Tsuchida, Mini-Rev. Med. Chem. 2008, 8, 175.
L. E. Gerweck, Semin. Radiat. Oncol. 1998, 8, 176.
J. H. Rao, ACS Nano 2008, 2, 1984.
P. Ghosh, G. Han, M. De, C. K. Kim, V. M. Rotello, Adv. Drug Delivery Rev. 2008, 60, 1307.
2007; 17
2007; 129
2004; 126
2006; 12
2008; 18
2003; 58
2007
2008; 7
2006; 18
2006
2008; 8
2008; 3
2009; 131
2004; 1
2008; 2
2008; 92
2003; 10
2009; 26
2009; 48
2004; 97
2006; 45
1984; 2
2005; 127
2002; 200
2008; 68
2009; 5
2008; 41
2008; 377
2007; 3
2009; 19
2003; 125
2007; 1
2008; 60
2009; 38
2008; 130
1975; 6
1998; 8
e_1_2_6_31_2
e_1_2_6_30_2
Pathak V. (e_1_2_6_5_2) 2007
Colilla M. (e_1_2_6_13_2) 2008; 3
Kumar C. S. S. R. (e_1_2_6_4_2) 2006
e_1_2_6_18_2
e_1_2_6_19_2
Nalwa H. S. (e_1_2_6_6_2) 2007
e_1_2_6_12_2
e_1_2_6_35_2
e_1_2_6_34_2
e_1_2_6_10_2
e_1_2_6_33_2
e_1_2_6_11_2
e_1_2_6_32_2
e_1_2_6_16_2
e_1_2_6_39_2
e_1_2_6_17_2
e_1_2_6_38_2
e_1_2_6_14_2
e_1_2_6_37_2
e_1_2_6_15_2
e_1_2_6_36_2
e_1_2_6_42_2
e_1_2_6_20_2
e_1_2_6_41_2
e_1_2_6_40_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_3_2
e_1_2_6_24_2
e_1_2_6_47_2
e_1_2_6_23_2
e_1_2_6_48_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_1_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_43_2
e_1_2_6_27_2
e_1_2_6_44_2
e_1_2_6_26_2
e_1_2_6_45_2
e_1_2_6_25_2
e_1_2_6_46_2
References_xml – reference: I. I. Slowing, B. G. Trewyn, S. Giri, V. S. Y. Lin, Adv. Funct. Mater. 2007, 17, 1225.
– reference: Z. Liu, K. Chen, C. Davis, S. Sherlock, Q. Cao, X. Chen, H. Dai, Cancer Res. 2008, 68, 6652.
– reference: W. J. Rieter, K. M. L. Taylor, W. Lin, J. Am. Chem. Soc. 2007, 129, 9852.
– reference: E. Boisselier, D. Astruc, Chem. Soc. Rev. 2009, 38, 1759.
– reference: W. J. Rieter, K. M. Pott, K. M. L. Taylor, W. Lin, J. Am. Chem. Soc. 2008, 130, 11584.
– reference: A. L. Doadrio, E. M. B. Sousa, J. C. Doadrio, J. Perez Pariente, I. Izquierdo-Barba, M. Vallet-Regi, J. Controlled Release 2004, 97, 125.
– reference: J. Lu, M. Liong, S. Sherman, T. Xia, M. Kovochich, A. E. Nel, J. I. Zink, F. Tamanoi, NanoBiotechnology 2007, 3, 89.
– reference: N. W. S. Kam, Z. Liu, H. Dai, Angew. Chem. Int. Ed. 2006, 45, 577.
– reference: S. Angelos, E. Johansson, J. F. Stoddart, J. I. Zink, Adv. Funct. Mater. 2007, 17, 2261.
– reference: S. S. Feng, S. Chien, Chem. Eng. Sci. 2003, 58, 4087.
– reference: M. Prato, K. Kostarelos, A. Bianco, Acc. Chem. Res. 2008, 41, 60.
– reference: M. Liong, S. Angelos, E. Choi, K. Patel, J. F. Stoddart, J. I. Zink, J. Mater. Chem. 2009, 19, 6251.
– reference: M. Y. Ma, Y. J. Zhu, L. Li, S. W. Cao, J. Mater. Chem. 2008, 18, 2722.
– reference: I. I. Slowing, J. L. Vivero-Escoto, C.-W. Wu, V. S. Y. Lin, Adv. Drug Delivery Rev. 2008, 60, 1278.
– reference: Z. Liu, X. M. Sun, N. Nakayama-Ratchford, H. J. Dai, ACS Nano 2007, 1, 50.
– reference: C. S. S. R. Kumar, Nanomaterials for Cancer Therapy, 1st ed., Wiley-VCH, Weinheim 2006.
– reference: V. Pathak, Nanotechnology for Cancer Therapy, Pearl Books, New Delhi 2007.
– reference: A. Hirano, T. Matsui, Hum. Pathol. 1975, 6, 611.
– reference: G. Pastorin, Pharm. Res. 2009, 26, 746.
– reference: A. Bianco, Expert Opin. Drug Delivery 2004, 1, 57.
– reference: J. Cheon, J. Mater. Chem. 2009, 19, 6249.
– reference: I. Izquierdo-Barba, M. Manzano, M. Colilla, M. Vallet-Regi, Key Eng. Mater. 2008, 377, 133.
– reference: X. Q. Huang, C. Y. Guo, L. Q. Zuo, N. F. Zheng, G. D. Stucky, Small 2009, 5, 361.
– reference: J. A. Firth, J. Anat. 2002, 200, 541.
– reference: M. Liong, J. Lu, M. Kovochich, T. Xia, S. G. Ruehm, A. E. Nel, F. Tamanoi, J. I. Zink, ACS Nano 2008, 2, 889.
– reference: P. M. Arnal, C. Weidenthaler, F. Schuth, Chem. Mater. 2006, 18, 2733.
– reference: D. Davis, U. Akhtar, B. Keaster, K. Grozinger, L. Washington, S. Kelsey, A. Sarkar, R. K. DeLong, J. Biomed. Nanotechnol. 2009, 5, 36.
– reference: K. M. L. Taylor, J. S. Kim, W. J. Rieter, H. An, W. Lin, W. Lin, J. Am. Chem. Soc. 2008, 130, 2154.
– reference: D. P. Ferris, Y.-L. Zhao, N. M. Khashab, H. A. Khatib, J. F. Stoddart, J. I. Zink, J. Am. Chem. Soc. 2009, 131, 1686.
– reference: Y. Piao, J. Kim, H. Bin Na, D. Kim, J. S. Baek, M. K. Ko, J. H. Lee, M. Shokouhimehr, T. Hyeon, Nat. Mater. 2008, 7, 242.
– reference: M. Vallet-Regi, Chem. -Eur. J. 2006, 12, 5934.
– reference: M. Colilla, M. Manzano, M. Vallet-Regi, Int. J. Nanomed. 2008, 3, 403.
– reference: K. Patel, S. Angelos, W. R. Dichtel, A. Coskun, Y.-W. Yang, J. I. Zink, J. F. Stoddart, J. Am. Chem. Soc. 2008, 130, 2382.
– reference: P. M. Arnal, M. Comotti, F. Schuth, Angew. Chem. Int. Ed. 2006, 45, 8224.
– reference: D. R. Radu, C.-Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, V. S. Y. Lin, J. Am. Chem. Soc. 2004, 126, 13216.
– reference: J. L. Wike-Hooley, J. Haveman, H. S. Reinhold, Radiother. Oncol. 1984, 2, 343.
– reference: H. S. Nalwa, T. J. Webster, Cancer Nanotechnology: Nanomaterials for Cancer Diagnosis and Therapy, American Scientific Publishers, Stevenson Ranch, CA 2007.
– reference: L. E. Gerweck, Semin. Radiat. Oncol. 1998, 8, 176.
– reference: Y. Klichko, M. Liong, E. Choi, S. Angelos, A. E. Nel, J. F. Stoddart, F. Tamanoi, J. I. Zink, J. Am. Ceram. Soc. 2008, 92, S2.
– reference: P. Ghosh, G. Han, M. De, C. K. Kim, V. M. Rotello, Adv. Drug Delivery Rev. 2008, 60, 1307.
– reference: W. Zhao, J. Gu, L. Zhang, H. Chen, J. Shi, J. Am. Chem. Soc. 2005, 127, 8916.
– reference: Z. Liu, J. T. Robinson, X. M. Sun, H. J. Dai, J. Am. Chem. Soc. 2008, 130, 10876.
– reference: C.-Y. Lai, B. G. Trewyn, D. M. Jeftinija, K. Jeftinija, S. Xu, S. Jeftinija, V. S. Y. Lin, J. Am. Chem. Soc. 2003, 125, 4451.
– reference: D. Pantarotto, D. Partidos Charalambos, J. Hoebeke, F. Brown, E. Kramer, J.-P. Briand, S. Muller, M. Prato, A. Bianco, Chem. Biol. 2003, 10, 961.
– reference: W. Lin, J. W. Rieter, K. M. L. Taylor, Angew. Chem. Int. Ed. 2009, 48, 650.
– reference: T. Murakami, K. Tsuchida, Mini-Rev. Med. Chem. 2008, 8, 175.
– reference: J. H. Rao, ACS Nano 2008, 2, 1984.
– reference: A. Corma, U. Diaz, M. Arrrica, E. Fernandez, I. Ortega, Angew. Chem. Int. Ed. 2009, 48, 6247.
– volume: 48
  start-page: 650
  year: 2009
  publication-title: Angew. Chem. Int. Ed.
– volume: 18
  start-page: 2733
  year: 2006
  publication-title: Chem. Mater.
– volume: 2
  start-page: 1984
  year: 2008
  publication-title: ACS Nano
– volume: 3
  start-page: 403
  year: 2008
  publication-title: Int. J. Nanomed.
– volume: 58
  start-page: 4087
  year: 2003
  publication-title: Chem. Eng. Sci.
– volume: 130
  start-page: 2154
  year: 2008
  publication-title: J. Am. Chem. Soc.
– volume: 8
  start-page: 176
  year: 1998
  publication-title: Semin. Radiat. Oncol.
– volume: 1
  start-page: 50
  year: 2007
  publication-title: ACS Nano
– volume: 377
  start-page: 133
  year: 2008
  publication-title: Key Eng. Mater.
– volume: 127
  start-page: 8916
  year: 2005
  publication-title: J. Am. Chem. Soc.
– volume: 18
  start-page: 2722
  year: 2008
  publication-title: J. Mater. Chem.
– volume: 45
  start-page: 8224
  year: 2006
  publication-title: Angew. Chem. Int. Ed.
– volume: 17
  start-page: 1225
  year: 2007
  publication-title: Adv. Funct. Mater.
– volume: 130
  start-page: 11584
  year: 2008
  publication-title: J. Am. Chem. Soc.
– volume: 6
  start-page: 611
  year: 1975
  publication-title: Hum. Pathol.
– volume: 19
  start-page: 6249
  year: 2009
  publication-title: J. Mater. Chem.
– volume: 45
  start-page: 577
  year: 2006
  publication-title: Angew. Chem. Int. Ed.
– year: 2007
– volume: 1
  start-page: 57
  year: 2004
  publication-title: Expert Opin. Drug Delivery
– volume: 41
  start-page: 60
  year: 2008
  publication-title: Acc. Chem. Res.
– volume: 2
  start-page: 889
  year: 2008
  publication-title: ACS Nano
– volume: 7
  start-page: 242
  year: 2008
  publication-title: Nat. Mater.
– volume: 125
  start-page: 4451
  year: 2003
  publication-title: J. Am. Chem. Soc.
– volume: 5
  start-page: 361
  year: 2009
  publication-title: Small
– volume: 10
  start-page: 961
  year: 2003
  publication-title: Chem. Biol.
– volume: 68
  start-page: 6652
  year: 2008
  publication-title: Cancer Res.
– volume: 5
  start-page: 36
  year: 2009
  publication-title: J. Biomed. Nanotechnol.
– volume: 12
  start-page: 5934
  year: 2006
  publication-title: Chem. ‐Eur. J.
– volume: 8
  start-page: 175
  year: 2008
  publication-title: Mini‐Rev. Med. Chem.
– volume: 131
  start-page: 1686
  year: 2009
  publication-title: J. Am. Chem. Soc.
– volume: 3
  start-page: 89
  year: 2007
  publication-title: NanoBiotechnology
– volume: 129
  start-page: 9852
  year: 2007
  publication-title: J. Am. Chem. Soc.
– volume: 97
  start-page: 125
  year: 2004
  publication-title: J. Controlled Release
– volume: 2
  start-page: 343
  year: 1984
  publication-title: Radiother. Oncol.
– year: 2006
– volume: 200
  start-page: 541
  year: 2002
  publication-title: J. Anat.
– volume: 92
  start-page: S2
  year: 2008
  publication-title: J. Am. Ceram. Soc.
– volume: 60
  start-page: 1278
  year: 2008
  publication-title: Adv. Drug Delivery Rev.
– volume: 60
  start-page: 1307
  year: 2008
  publication-title: Adv. Drug Delivery Rev.
– volume: 130
  start-page: 2382
  year: 2008
  publication-title: J. Am. Chem. Soc.
– volume: 48
  start-page: 6247
  year: 2009
  publication-title: Angew. Chem. Int. Ed.
– volume: 130
  start-page: 10876
  year: 2008
  publication-title: J. Am. Chem. Soc.
– volume: 126
  start-page: 13216
  year: 2004
  publication-title: J. Am. Chem. Soc.
– volume: 17
  start-page: 2261
  year: 2007
  publication-title: Adv. Funct. Mater.
– volume: 38
  start-page: 1759
  year: 2009
  publication-title: Chem. Soc. Rev.
– volume: 26
  start-page: 746
  year: 2009
  publication-title: Pharm. Res.
– volume: 19
  start-page: 6251
  year: 2009
  publication-title: J. Mater. Chem.
– ident: e_1_2_6_37_2
  doi: 10.1002/anie.200803387
– volume-title: Cancer Nanotechnology: Nanomaterials for Cancer Diagnosis and Therapy
  year: 2007
  ident: e_1_2_6_6_2
– ident: e_1_2_6_19_2
  doi: 10.1021/nn800072t
– ident: e_1_2_6_27_2
  doi: 10.1021/ja028650l
– ident: e_1_2_6_12_2
  doi: 10.1021/nn800669n
– ident: e_1_2_6_24_2
  doi: 10.1021/ja710193c
– ident: e_1_2_6_15_2
  doi: 10.1021/ja807798g
– ident: e_1_2_6_17_2
  doi: 10.1111/j.1551-2916.2008.02722.x
– ident: e_1_2_6_30_2
  doi: 10.1007/s11095-008-9811-0
– ident: e_1_2_6_7_2
  doi: 10.1039/b914842f
– ident: e_1_2_6_36_2
  doi: 10.1038/nmat2118
– ident: e_1_2_6_2_2
  doi: 10.1046/j.1469-7580.2002.00059.x
– ident: e_1_2_6_22_2
  doi: 10.1021/ja046275m
– ident: e_1_2_6_1_2
  doi: 10.1016/S0009-2509(03)00234-3
– ident: e_1_2_6_46_2
  doi: 10.1002/smll.200800808
– volume-title: Nanotechnology for Cancer Therapy
  year: 2007
  ident: e_1_2_6_5_2
– ident: e_1_2_6_43_2
  doi: 10.1016/S0167-8140(84)80077-8
– ident: e_1_2_6_26_2
  doi: 10.1021/ja051113r
– volume-title: Nanomaterials for Cancer Therapy
  year: 2006
  ident: e_1_2_6_4_2
– ident: e_1_2_6_10_2
  doi: 10.1016/j.addr.2008.03.016
– ident: e_1_2_6_47_2
  doi: 10.1021/nn700040t
– ident: e_1_2_6_11_2
  doi: 10.2174/138955708783498078
– ident: e_1_2_6_41_2
  doi: 10.1002/adfm.200601217
– ident: e_1_2_6_40_2
  doi: 10.1016/j.addr.2008.03.012
– ident: e_1_2_6_45_2
  doi: 10.1021/cm052580a
– ident: e_1_2_6_8_2
  doi: 10.1039/b806051g
– ident: e_1_2_6_14_2
  doi: 10.1016/j.jconrel.2004.03.005
– ident: e_1_2_6_25_2
  doi: 10.1002/chem.200600226
– ident: e_1_2_6_28_2
  doi: 10.1016/j.chembiol.2003.09.011
– ident: e_1_2_6_42_2
  doi: 10.1016/S1053-4296(98)80043-X
– ident: e_1_2_6_20_2
  doi: 10.1007/s12030-008-9003-3
– ident: e_1_2_6_21_2
  doi: 10.1021/ja0772086
– ident: e_1_2_6_3_2
  doi: 10.1016/S0046-8177(75)80045-1
– ident: e_1_2_6_9_2
  doi: 10.1166/jbn.2009.1005
– ident: e_1_2_6_33_2
  doi: 10.1002/anie.200503389
– ident: e_1_2_6_16_2
  doi: 10.4028/www.scientific.net/KEM.377.133
– ident: e_1_2_6_18_2
  doi: 10.1039/b902462j
– ident: e_1_2_6_48_2
  doi: 10.1021/ja803688x
– ident: e_1_2_6_34_2
  doi: 10.1039/b800389k
– ident: e_1_2_6_35_2
  doi: 10.1002/anie.200902208
– ident: e_1_2_6_38_2
  doi: 10.1021/ja803383k
– ident: e_1_2_6_39_2
  doi: 10.1021/ja073506r
– ident: e_1_2_6_23_2
  doi: 10.1002/adfm.200601191
– ident: e_1_2_6_31_2
  doi: 10.1021/ar700089b
– ident: e_1_2_6_32_2
  doi: 10.1158/0008-5472.CAN-08-1468
– volume: 3
  start-page: 403
  year: 2008
  ident: e_1_2_6_13_2
  publication-title: Int. J. Nanomed.
– ident: e_1_2_6_44_2
  doi: 10.1002/anie.200603507
– ident: e_1_2_6_29_2
  doi: 10.1517/17425247.1.1.57
SSID ssj0017734
Score 2.4311714
Snippet Hollow mesoporous zirconia nanocapsules (hm‐ZrO2) with a hollow core/porous shell structure are demonstrated as effective vehicles for anti‐cancer drug...
Hollow mesoporous zirconia nanocapsules ( hm ‐ZrO 2 ) with a hollow core/porous shell structure are demonstrated as effective vehicles for anti‐cancer drug...
SourceID crossref
wiley
istex
SourceType Enrichment Source
Index Database
Publisher
StartPage 2442
SubjectTerms doxorubicin
drug delivery
hollow nanostructure
nanocapsules
Title Hollow Mesoporous Zirconia Nanocapsules for Drug Delivery
URI https://api.istex.fr/ark:/67375/WNG-DB7C7ZVK-2/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fadfm.201000647
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LT8IwGG8MXvTg24iv7GD0NGAtW-kRmUg0cDCihMvS9WEIyMxg8fHX-3WDCSbGRA87LP26dN-rv25ff0XojCgwugPOW9UQ5FUslF0TEtuYV7ShM2NYms3J7Y7X6lZvem5vYRd_xg-Rf3AzkZHmaxPgPJyUv0hDudTPaWlWul8SkrAp2DKo6C7nj3IozX4re44p8HJ6c9bGCi4vd1-alVaNgt-W0Wo63TQ3EZ8PNKsyGZaSaVgSH984HP_zJltoY4ZFrXrmPNtoRY130PoCQ-EuYi3wk-jVaqtJBEg9SiZWfxDDGnrALUjMMBHCKnukJhZgX8uPkyfLh8FAeLzvoW7z6r7RsmenLdjCkOLZBFMtWKglIUyCoQyRGFcVR3iuYk6oqdRezatxaHMdDs2GqZ4aQEgoIXDto8I4GqsDZOlQcEkl45JDggg505QBMJUOFURTzYrInms7EDMqcnMixijISJRxYFQS5Copootc_iUj4fhR8jw1Xi7G46EpXaNu8Ni5DvxL2qD9h9sAFxFOTfLL84K632znd4d_6XSE1rKKA1NmcowK0zhRJwBkpuFp6qyf0H3n3A
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NT9swFH8Cehg7bDCG1sG2HBA7hTZOG9dHaNZ19OMwtQz1Yjn-QFW7duqHNvjreS9psxUJTYJDDpHtyH4f9rPz8-8BnIQWlR6g8VYcOnmFaevXtGE-U2VHdGaCGbqc3OlGzX7l8rq6RhPSXZiMHyI_cCPPSOdrcnA6kC79ZQ1Vxv1MsVnphcltKFBab0piEH_PGaQCzrMfy1FAEK_ges3bWGalzfYb61KBRPxnM15NF5zGa0jWXc1wJqOz5SI503cPWByfNZY9eLUKR73zzH72YctO3sDLf0gKD0A00VSmv72OnU8xWJ8u595gOMNt9FB5ODfjWogb7bGdexj-evFseePF2Bv0kNu30G986dWb_irhgq-JF88PGXdaJM6EoTCoK-ISU7Yc6KhqRZA4blxUi2oKy6qBwmIiq-cUE4Y8DPE5hJ3JdGLfgecSrQw3QhmFc0SihOMCY1MTcB067kQR_LW4pV6xkVNSjLHMeJSZJJHIXCRF-JzX_5XxcDxa8zTVXl5NzUaEXuNV-aP7VcYXvM4HVy3JisBSnfzne_I8bnTyt_dPafQJXjR7nbZsf-u2jmA3AyAQ6uQYdhazpf2Acc0i-Zha7j1g8ev2
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFH6oBdGDu1jXHERP0WbSZjpHNdZqbRFxKV6GySxSWlvpgsuv903SRiuIoIccwsyEyVu_Sd58A7Dra1S6h8abN-jkeSK1W5SKuETkjKUzY0TZzcnVWlC-zV_UC_Uvu_gTfoj0g5v1jDheWwd_VubwkzRUKPMUl2bF-yUnIZMP0GMsLLpOCaQ8SpP_yoFnK7y8-oi2MUcOx8ePpaWMlfDrOFyN801pHsRopkmZSfNg0I8O5Ps3Esf_vMoCzA3BqHOUWM8iTOj2Esx-oShcBlZGQ-m8OFXd6yBU7wx6zkOji4vohnAwMmMmxGV2S_ccBL9O2B08OiFOBv3jbQVuS6c3J2V3eNyCKy0rnusTaiSLjPJ9plBTlklM6Jwng4JmXmSoMkExKApsK3gCmy1VPbWI0Ke-j9cqTLU7bb0GjomkUFQxoQRGiEgwQxkiU-VR6RtqWBbckbS5HHKR2yMxWjxhUSbcioSnIsnCftr_OWHh-LHnXqy8tJvoNm3tGi3w-9oZD4_pCX24q3CSBRKr5Jfn8aOwVE3v1v8yaAemr8ISvzyvVTZgJqk-sCUnmzDV7w70FoKafrQd2-0Hu0nqrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hollow+Mesoporous+Zirconia+Nanocapsules+for+Drug+Delivery&rft.jtitle=Advanced+functional+materials&rft.au=Tang%2C+Shaoheng&rft.au=Huang%2C+Xiaoqing&rft.au=Chen%2C+Xiaolan&rft.au=Zheng%2C+Nanfeng&rft.date=2010-08-09&rft.pub=WILEY-VCH+Verlag&rft.issn=1616-301X&rft.eissn=1616-3028&rft.volume=20&rft.issue=15&rft.spage=2442&rft.epage=2447&rft_id=info:doi/10.1002%2Fadfm.201000647&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_DB7C7ZVK_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1616-301X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1616-301X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1616-301X&client=summon